Countering this argument is a previous LOOP substudy that found that any effect of ILR screening on outcomes was upheld by the healthier participants, not those with established cardiovascular disease.23 In addition, previous research suggests that NT-proBNP may serve as an etiological indicator of ischemic stroke. The gene discussed is NPPB; the disease is ischemic stroke.